Monday, 20 October 2008
Once-Daily VYVANSE(R) Significantly Improved ADHD Symptoms In One Of The Largest Controlled Stimulant Trials In Adults With ADHD
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that a study published in the September issue of the Journal of Clinical Psychiatry found once-daily VYVANSE significantly improved Attention Deficit Hyperactivity Disorder (ADHD) symptoms in adults within the first week of treatment. This study is the phase 3 pivotal trial submitted to the FDA and supported the approval in April 2008 of VYVANSE for adults with ADHD.
ADHD Stimulant Treatment May Decrease Risk Of Substance Abuse In Adolescent Girls
Massachusetts General Hospital (MGH) researchers have found that treatment with stimulant drugs does not increase and appears to significantly decrease the risk that girls with ADHD will begin smoking cigarettes or using alcohol or drugs. Their report in the October Archives of Pediatrics and Adolescent Medicine parallels the findings of several earlier studies in boys, which needed to be confirmed in girls.
Many Factors To Consider In Getting Treatment Right For ADHD
The quality of a child's relationships and their diet are now known to be minor risk factors implicated in attention deficit hyperactivity disorder (ADHD). Biological factors, including genetics, remain the most significant factor, however, so they must all be considered before treatment can begin. "ADHD is rarely encountered as a pure, discrete disorder," says Professor Alasdair Vance from the Royal Children's Hospital in Melbourne.
Manhattan Research Announces Top Condition Groups Shifting Their TV Viewing Online
Acne and attention deficit hyperactivity disorder (ADHD) patients are the condition groups most likely to watch streaming or downloaded television programs on the Internet, according to pharmaceutical and healthcare market research company Manhattan Research's just released Cybercitizen^ Health v8.0 consumer study and strategic advisory service. The study also found that consumer media preferences overall are evolving - less than half of U.S.
Supersensitive Receptor Engineered By Caltech Scientists Improves Understanding Of Dopamine System
Genetically modifying a receptor found on the neurons that produce the neurotransmitter dopamine has given California Institute of Technology (Caltech) researchers a unique glimpse into the workings of the brain's dopamine system--as well as a new target for treating diseases that result from either too much or too little of this critical neurotransmitter.
Research Shows A Walk In The Park Improves Attention In Children With ADHD
For children with Attention Deficit Hyperactivity Disorder (ADHD) tasks that require concentration such as doing homework or taking a test can be very difficult. A simple, inexpensive remedy may be a "dose of nature." A study conducted at the University of Illinois shows that children with ADHD demonstrate greater attention after a 20-minute walk in a park than after a similar walk in a downtown area or a residential neighborhood.
Thursday, 2 October 2008
Advice About Heart Tests Before ADHD Treatment
Stimulant medications like those often prescribed for children with attention deficit hyperactivity disorder (ADHD) raise blood pressure and heart rate, and some drugs carry warning labels for patients with heart problems. Two professional organizations are at odds over whether routine electrocardiogram (ECG) testing is necessary before a child starts taking a medication for ADHD, reports the October 2008 issue of the Harvard Mental Health Letter.
Study Finds Young Children Can Develop Full-blown OCD
A new study by researchers at the Bradley Hasbro Children's Research Center has found that children as young as four can develop full-blown obsessive compulsive disorder (OCD) and often exhibit many of the same OCD characteristics typically seen in older kids. The study, published online by the Journal of Psychopathology and Behavioral Assessment, is the largest sample of young children with OCD published to date.
The Mental Capacity Act Explained, UK
A clear and easy to understand DVD guide to The Mental Capacity Act (MCA) 2005, has been produced by national charity for people with learning disabilities, HFT, for the Department of Health and Social Care Institute for Excellence, as part of a programme of work on implementing the MCA 2005.
Subscribe to:
Posts (Atom)